MKM Partners commented on Amarin Corporation (NASDAQ: AMRN) Monday as Vascepa prescription continue to gain momentum although sales might fall ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE